The British Horseracing Authority (BHA) has announced a new initiative aimed at combating potential gene doping in racehorses, marking a significant development in the integrity of horse racing in the UK. As part of its expanded anti-doping programme, the BHA has allocated nearly £2 million for comprehensive research into the detection methods associated with gene manipulation techniques.

While the BHA has indicated that there is currently no evidence of gene doping being employed in racing, the organisation is taking proactive steps to safeguard against potential future risks of corruption in the sport. Gene doping is described as the practice of using genetic or cellular manipulation of DNA, which can involve gene editing or transfer techniques. These methods are intended to enhance an athlete’s performance or expedite their recovery after exertion.

The BHA’s decision underscores its commitment to maintaining the integrity of British racing, ensuring that the sport remains fair and free from modern doping techniques that leverage advancements in genetic research and technology. By implementing these measures, the BHA aims to stay ahead of potential challenges within the industry and reassure stakeholders about the integrity of competitive racing.

Source: Noah Wire Services